Patent · US Active

Cytotoxic agents and conjugates thereof

US10654873B2 · kind B2 · utility

0Cited by
4References
32Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 15, 2017
Grant dateMay 19, 2020
Priority date
Expiry dateSep 15, 2037

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are novel maytansinoid compounds of general formula I. Also provided herein are conjugates comprising the compounds linked to a binding protein via a linker, and conjugating reagents comprising the compounds attached via a linker to at least one functional group capable of reacting with a binding protein. Also provided herein are pharmaceutical compositions comprising the compounds and conjugates, therapeutic methods and uses involving the compounds and conjugates, for example in cancer therapy, and novel synthetic processes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.